463 related articles for article (PubMed ID: 17465527)
21. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
[TBL] [Abstract][Full Text] [Related]
22. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux.
Chavanpatil MD; Patil Y; Panyam J
Int J Pharm; 2006 Aug; 320(1-2):150-6. PubMed ID: 16713148
[TBL] [Abstract][Full Text] [Related]
23. Paclitaxel coating of the luminal surface of hemodialysis grafts with effective suppression of neointimal hyperplasia.
Baek I; Bai CZ; Hwang J; Nam HY; Park JS; Kim DJ
J Vasc Surg; 2012 Mar; 55(3):806-814.e1. PubMed ID: 22226184
[TBL] [Abstract][Full Text] [Related]
24. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.
Derakhshandeh K; Erfan M; Dadashzadeh S
Eur J Pharm Biopharm; 2007 Apr; 66(1):34-41. PubMed ID: 17070678
[TBL] [Abstract][Full Text] [Related]
25. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles.
Chung TW; Wang SS; Tsai WJ
Biomaterials; 2008 Jan; 29(2):228-37. PubMed ID: 17953984
[TBL] [Abstract][Full Text] [Related]
26. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
[TBL] [Abstract][Full Text] [Related]
27. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin.
Yin Y; Chen D; Qiao M; Lu Z; Hu H
J Control Release; 2006 Dec; 116(3):337-45. PubMed ID: 17097180
[TBL] [Abstract][Full Text] [Related]
28. Characterization of perivascular poly(lactic-co-glycolic acid) films containing paclitaxel.
Jackson JK; Smith J; Letchford K; Babiuk KA; Machan L; Signore P; Hunter WL; Wang K; Burt HM
Int J Pharm; 2004 Sep; 283(1-2):97-109. PubMed ID: 15363506
[TBL] [Abstract][Full Text] [Related]
29. [Surface-modified paclitaxel-loaded nanoparticles as local delivery system for the prevention of vessel restenosis].
Mei L; Song CX; Jin X; Che YZ; Jin Z; Sun HF
Yao Xue Xue Bao; 2007 Jan; 42(1):81-6. PubMed ID: 17520813
[TBL] [Abstract][Full Text] [Related]
30. Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release.
Saxena V; Sadoqi M; Shao J
Int J Pharm; 2004 Jul; 278(2):293-301. PubMed ID: 15196634
[TBL] [Abstract][Full Text] [Related]
31. Preparation and in vitro anticancer activity of wheat germ agglutinin (WGA)-conjugated PLGA nanoparticles loaded with paclitaxel and isopropyl myristate.
Mo Y; Lim LY
J Control Release; 2005 Sep; 107(1):30-42. PubMed ID: 16051391
[TBL] [Abstract][Full Text] [Related]
32. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
Jackson JK; Hung T; Letchford K; Burt HM
Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
[TBL] [Abstract][Full Text] [Related]
33. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery.
Kim DH; Martin DC
Biomaterials; 2006 May; 27(15):3031-7. PubMed ID: 16443270
[TBL] [Abstract][Full Text] [Related]
34. Release of paclitaxel from polylactide-co-glycolide (PLGA) microparticles and discs under irradiation.
Wang J; Ng CW; Win KY; Shoemakers P; Lee TK; Feng SS; Wang CH
J Microencapsul; 2003; 20(3):317-27. PubMed ID: 12881113
[TBL] [Abstract][Full Text] [Related]
35. Suppression of neointimal hyperplasia by sirolimus-eluting expanded polytetrafluoroethylene (ePTFE) haemodialysis grafts in comparison with paclitaxel-coated grafts.
Baek I; Bai CZ; Hwang J; Park J; Park JS; Kim DJ
Nephrol Dial Transplant; 2012 May; 27(5):1997-2004. PubMed ID: 22058173
[TBL] [Abstract][Full Text] [Related]
36. Poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy.
Dong Y; Feng SS
Int J Pharm; 2007 Sep; 342(1-2):208-14. PubMed ID: 17560058
[TBL] [Abstract][Full Text] [Related]
37. Development of expanded polytetrafluoroethylene cardiovascular graft platform based on immobilization of poly lactic-co-glycolic acid nanoparticles using a wet chemical modification technique.
Al Meslmani BM; Mahmoud GF; Bakowsky U
Int J Pharm; 2017 Aug; 529(1-2):238-244. PubMed ID: 28689963
[TBL] [Abstract][Full Text] [Related]
38. The effect of paclitaxel-loaded nanoparticles with radiation on hypoxic MCF-7 cells.
Jin C; Wu H; Liu J; Bai L; Guo G
J Clin Pharm Ther; 2007 Feb; 32(1):41-7. PubMed ID: 17286788
[TBL] [Abstract][Full Text] [Related]
39. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
[TBL] [Abstract][Full Text] [Related]
40. Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations.
Zhang Z; Wang X; Li B; Hou Y; Yang J; Yi L
Drug Deliv; 2018 Nov; 25(1):166-177. PubMed ID: 29299936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
